Skip to main content

ASU brings drive-thru COVID-19 testing to Lake Havasu City

ASU at Lake Havasu supports the state’s western region with free saliva-based diagnostic testing on Oct. 2

Man in protective gear reaching into a car
September 29, 2020

Arizona’s Mohave County is experiencing long wait times for COVID-19 test results, but ASU at Lake Havasu is helping to relieve some of the bottleneck.

The university is teaming up with Lake Havasu City and the Arizona National Guard to offer free saliva-based diagnostic testing, event staffing and a drive-thru site location to residents of Mohave County and Lake Havasu City at large.

“ASU at Lake Havasu is proud to partner with Mayor Cal Sheehy, Lake Havasu City and the ASU Biodesign Institute to bring additional COVID testing options to the western region of Arizona,” said Carla J. Harcleroad, director of ASU at Lake Havasu. “This is an example of ASU’s commitment to the communities we serve.”

The event is slated for Friday, Oct. 2, at the Lake Havasu City Aquatic and Community Center located at 100 Park Ave. Event hours will run from 8 a.m. to 1 p.m., and test results are usually delivered within 24–48 hours. The Arizona National Guard Medical Division will provide five staff members to administer the tests. Preregistration is required, and the agency code for scheduling is SALIVATEST.

Sheehy said the current typical wait time for COVID-19 test results in the Lake Havasu City area is about 7-10 days, and he felt that was too long.

“Test results were taking a considerable amount of time, and the city was looking for additional options for our community. That’s when this opportunity with ASU presented itself,” said Sheehy, who has partnered with ASU at Lake Havasu on many community-related issues such as the environment, sustainability, volunteer work and fundraising. This is central to ASU’s Charter commitment to be fundamentally responsible for the economic, social, cultural and overall health of the communities it serves.

The saliva-based diagnostic testing was conceived by ASU’s Biodesign Institute and designed with an eye for speed, scale and convenience. The testing process usually takes about 10–20 minutes and participants don’t even have to leave their vehicles.

“The process is easy and painless,” said David Thomas, CEO of ASURE, who works with the team providing public testing for ASU. “When you arrive at the site you get a sample tube, find a comfortable parking space to collect the sample, hand off the tube on the way out, and go about your day.”

The Biodesign Institute announced in May that it had developed the first saliva-based COVID-19 test for front-line health care workers, critical infrastructure and public safety personnel. Since then they have hosted several events throughout the state through a partnership with the Arizona Department of Health Services. ASU has also been using the saliva-based test with employees and students. To date, more than 36,000 Arizonans have received testing free of charge through ASU/state of Arizona partner testing sites.

In addition to the Phoenix area, ASU has hosted testing in Tucson, Flagstaff, Winkleman, Safford, Parker and Salome. The university also has plans to visit Nogales and Rio Rico in mid-October.

Top photo: Throughout the course of the pandemic, ASU's Biodesign Institute has played a major role in tracking COVID-19. Now, the university has developed a free saliva-based diagnostic test for Arizona communities.

More Science and technology


Two men in suits shake hands

Department of State and ASU announce new initiative to build resilient international microelectronics supply chain

Well known by now is that the CHIPS and Science Act of 2022 was designed to re-establish semiconductor manufacturing, research and development in the United States — onshoring, as it is sometimes…

A group of people in suits pose next to a U.S. flag.

ASU president, national council urge action to fuel US tech leadership

Arizona State University President Michael Crow and other members of a national advisory council on innovation and entrepreneurship presented their findings at the White House last week, calling for…

Zoomed-in photo of a protein neuron.

New research challenges conventional picture of Parkinson's disease

Parkinson's disease, the second most common type of progressive dementia after Alzheimer's disease, affects nearly 1 million people in the U.S. and an estimated 10 million individuals worldwide. Each…